According to the latest report published by Data Bridge Market Research, the Hormone-Refractory Oncology Drug Market  CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period An international Hormone-Refractory Oncology Drug...